Your English writing platform
Discover LudwigSuggestions(2)
Exact(1)
There were no differences between the ITT and PP baseline populations (data not shown).
Similar(59)
Patient baseline demographics and clinical characteristics were balanced across the tocilizumab-SC and tocilizumab-IV groups in the PP (table 1) and safety populations (data not shown).
This study provides baseline population data on chronic NCDs risk factors which are not readily available in many low-middle income countries.
As we expected not to have a complete baseline population data from the system, we tested if S tructure could be used to overcome the problem.
In the subgroup (with statistically similar baseline characteristics as the whole population, data not shown) of 68 patients in which IHC stains were performed, 29 (85%) of the 34 patients who had been treated with H. pylori eradication therapy had a negative IHC stain, compared to 72121%) of the 34 patients in the placebo group (P < 0.001).
For each of the studies, we identified long-term participants (n) and the remainder of the baseline population (m) in the total baseline population data file (m + n).
Demographic and baseline characteristics of the Japan + Korea patients in the Safety population (data not shown) were consistent with the Efficacy population (Table 1).
Data analysis for the sub-population with hypertension at baseline (84% of the study population) gave very similar results to those of the whole population (data not shown).
Baseline data for the per-protocol population did not differ from those of the intention-to-treat population (data not shown).
aegilopoides RIL population (data not shown).
All other baseline characteristics of the mothers and children and trial outcome measures were not different between the follow-up group and the total MiG population (data not shown).
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com